Skip Navigation
 
 
 
 
 
Print This Page
Share this page: More
 

Margolis, Russell L., M.D.

Dr. Russ Margolis

Professor of Psychiatry and Neurology
Clinical Director, Johns Hopkins Schizophrenia Center
Director, Genetic Neurobiology Laboratory
Co-Director, Division of Neurobiology

Co-Director, Baltimore Huntington’s Disease Center

Main Office Address

Division of Neurobiology
Department of Psychiatry and Behavioral Sciences
CMSC 8-121
The Johns Hopkins Hospital
600 North Wolfe St.
Baltimore, MD 21287-5371

Phone: 410-614-4262
Fax: 443-927-7965

E-mail: rmargoli@jhmi.edu

Administrative Assistant

Kathleen Ziolkowski
Email: kz@jhmi.edu
Phone:  410-614-0014

Education and Government Service

1982

A.B.

Princeton University

1986

M.D.

Johns Hopkins University School of Medicine

1986-1987

Medicine-Psychiatry Internship

Francis Scott Key Hospital

1987-1990

Psychiatry Residency

Johns Hopkins

1990-1992

Neurobiology Fellowship

National Institute of Mental Health

1990-1992

Government Service

Public Health Service

Professional Interests

My research interests revolve around the interface of psychiatry, neurology, and genetics.  A major focus is on the etiology, pathogenesis, and psychiatric aspects of neurodegenerative disorders affecting the cerebellum and basal ganglia, including Huntington’s disease, Huntington’s disease-like 2 (discovered by our group), and the cerebellar ataxias.  A second emphasis is on the genetic etiology and pathogenesis of schizophrenia, including the role of rare mutations of major effect, the potential utility of induced pluripotent stem cells as disease models, and novel approaches to mutation detection.  We are particularly interested in the etiologic and pathogenic properties of unstable DNA, RNA toxicity, and bidirectional transcription. My clinical interests include schizophrenia, affective disorders, and neuropsychiatry. 

Click here to learn more about Dr. Margolis' research

Click here for Hopkins Brain Wise Newsletter articles about Dr. Margolis' work

Selected Publications

Holmes SE, O’Hearn E, Callahan C, Hwang HS, Rosenblatt A, Ingersoll-Ashworth RG, Fleisher A, Stevanin G, Brice A, Potter NT, Ross CA, Margolis RL. A CTG trinucleotide repeat expansion in Junctophilin 3 is associated with Huntington's Disease-Like 2 (HDL2).  Nature Genetics, 29 (2001): 377-378.

Sachs NA, Sawa A, Holmes SE, Ross CA, DeLisi LE, Margolis RL.  A frameshift mutation in Disrupted in Schizophrenia 1 segregates with schizophrenia and schizoaffective disorder in an American family.  Molecular Psychiatry 10(2005) 758-64

Rudnicki DD, Holmes SE, Lin M, Thorton CA, Ross CA, Margolis RL.  Huntington’s disease-like 2 is associated with CUG repeat containing RNA foci.  Annals of Neurology, 61 (2007):272-82.

Rudnicki DD, Pletnikova O, Vansattel JP, Ross CA, Margolis RL.  A comparison of Huntington’s disease and Huntington’s disease-like 2 neuropathology.  Journal of Neuropathology and Experimental Neurology, 366-74.

Ross CA, Margolis RL. Schizophrenia: A point of disruption. Nature, 458 (2009):976-7

 

 
100th Anniversary Banner
Giving
Great Works

GREAT WORKS: 100 Years of Philanthropy in Service of Hopkins Psychiatry.

 

     

Research Volunteers Needed

Psychiatry E-News Update

For Faculty & Staff

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.

Privacy Policy and Disclaimer